Status:
COMPLETED
A Study for Patients With Osteoporosis
Lead Sponsor:
Eli Lilly and Company
Conditions:
Osteoporosis
Eligibility:
All Genders
40-85 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effect of injectable teriparatide to intranasal salmon calcitonin on lumbar spine bone mineral density, in the treatment of Chinese patients with establishe...
Eligibility Criteria
Inclusion
- Clinical diagnosis of osteoporosis
- No other severe disabling conditions
- Should have at least 1 vertebral or non-vertebral prevalent fracture, and bone mineral density T-score should be less than -2.5
- Ambulatory
- Men (aged 40 to 85 years) or postmenopausal women (aged 55 to 85 years)
Exclusion
- History of a disease that affects bone metabolism
- History of treatment with any drug that may significantly affect bone metabolism
- History or presence of liver disease
- History or presence of kidney disease
- History of excessive alcohol drinking or drug abuse
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
364 Patients enrolled
Trial Details
Trial ID
NCT00414973
Start Date
December 1 2006
End Date
July 1 2008
Last Update
October 28 2009
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Beijing, China, 100050
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chengdu, China, 610041
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Nanjing, China, 210029
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Shanghai, China, 200023